Axios @axios
The Biden administration's decision last week to continue restricting Medicare coverage for a class of Alzheimer's drugs has angered some Republicans. It renewed a thorny debate over when seniors should have access to new treatments. https://t.co/gbn5rHWyQs — PolitiTweet.org